Administration of a second generation perfluorochemical in combination with hyperbaric oxygenation does not provide additional benefit in a model of permanent middle cerebral artery occlusion in rats

OBJECTIVE: Both, second generation perfluorochemicals (Oxycyte®) and hyperbaric oxygen (HBO) have been shown to reduce necrotic tissue volume if administered early after experimental cerebral ischemia. With the idea of exponentiation of oxygen delivery to ischemic tissue, this study was conducted to...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Ulf C, Karutz, Tobias, Schilling, Lothar, Woitzik, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320177/
https://www.ncbi.nlm.nih.gov/pubmed/25674426
http://dx.doi.org/10.1186/2193-1801-3-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320177/
https://www.ncbi.nlm.nih.gov/pubmed/25674426
http://dx.doi.org/10.1186/2193-1801-3-32

Ejemplares similares